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efficacy of resistance to Francisella 
imparted by iTY/nraMP/slc11a1 
Depends on route of infection
Daniel A. Powell* and Jeffrey A. Frelinger
Department of Immunobiology, University of Arizona, Tucson, AZ, USA
Natural resistance-associated macrophage protein (NRAMP) encoded by the Slc11a1 
gene is a membrane-associated transporter of divalent metal ions. Murine Slc11a1 has 
two known alleles, a functional Slc11a1Gly169, which is found in DBA2/J, NOD/LtJ, and 
129p3/J and related mouse strains, and a non-functional Slc11a1Asp169, that is found in 
C56Bl/6J (B6) and BALB/cJ mice. B6 mice congenic for Slc11a1Gly169 (B6-Slc11a1G169) 
are markedly resistant to the intracellular pathogens Salmonella, Leishmania, and 
Mycobacterium tuberculosis. We examined the host cell response and replication of 
Francisella in B6-Slc11a1G169 mice. Bone marrow-derived macrophages from either 
B6-Slc11a1G169 or B6 mice were both effectively invaded by Francisella live vaccine strain 
(LVS). However, at 16 hours post-infection (hpi), the number of LVS bacteria recovered 
from B6 macrophages had increased roughly 100-fold, while in B6-Slc11a1G169 mice 
the number decreased 10-fold. When the mice were challenged intranasally (i.n.) B6 
mice lost significant amounts (~15%) of weight, where as B6-Slc11a1G169 mice lost no 
weight. Three days after infection in B6-Slc11a1G169 mice, we failed to recover viable 
Francisella from the lungs, livers, or spleens. By contrast, B6 mice had bacterial burdens 
approaching 1 × 106 CFU/organ in all three organs. To further examine the degree of 
resistance imparted by Slc11a1Gly169 expression, we challenged mice deficient in TLR2, 
TLR4, and TLR9, but expressing the functional Slc11a1 (B6-Slc11a1G169 Tlr2/4/9−/−). 
Surprisingly, B6-Slc11a1G169 Tlr2/4/9−/− mice had no notable weight loss. Eighty percent 
of B6-Slc11a1G169 Tlr2/4/9−/− mice yielded no detectable Francisella in any organ tested. 
Additionally, Slc11a1G169 produced little detectable cytokine either in the lung or serum 
compared to B6 mice. Mice expressing Slc11a1Gly169 survived even high doses (~80 
LD50) of LVS inoculation. These data taken together serve to highlight that functional 
Slc11a1Gly169 can compensate the lack of TLR2/4/9. Thus Slc11a1 is a critical player in 
murine resistance to pulmonary Francisella infection, but not footpad infection.
Keywords: slc11a1, natural resistance-associated macrophage protein, host response, Francisella tularensis, 
mouse genetics
inTrODUcTiOn
Many host genes have been implicated in the control of intracellular bacterial infections. The Slc11a 
gene was originally described as responsible for immunity to Salmonella (Ity) and has been found 
to function in many other intracellular bacterial infections including Mycobacterium tuberculosis 
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(1–3). Common inbred mice carry one of two different alleles 
for Sc11a1. C57BL/6 (B6) and BALB/c the most commonly used 
inbred mouse strains in immunology carry a non-functional vari-
ant (G169D) allele (Slc11a1−). C3H and 129 (and other strains) 
carry the functional allele 169G (Slc11a1+).
The innate immune response to Francisella tularensis (Ft) 
has been the subject of investigation for the past decade. Ft is 
a Gram-negative, facultative intracellular pathogen. In vivo and 
in vitro Ft largely infects myeloid cells. Based on its role in other 
intracellular bacterial infections, we hypothesized that Slc11a1 
would impact Francisella infection. However, nearly all reports of 
Francisella immunity have used either B6 or BALB/c mice, elimi-
nating the ability to detect the impact of Slca11a on the infection 
(4). There is one early report that investigated the role of Slc11a1, 
and compared B10 mice and a congenic line B10.A-slca11a1G169 
following footpad challenge with Francisella strain live vaccine 
strain (LVS) (5). In that report they concluded that not only was 
a functional Slc11a not protective, but slightly increased suscep-
tibility as measured by bacterial load in the spleen. However, 
no survival data were reported. One other report examined a 
sampling of inbred strains, including C3H and 129 that express 
functional Slca11a were not markedly more resistant to the most 
highly pathogenic Francisella strain, suggesting that Slc11a1 was 
not sufficient to mediate protection in that setting (6).
Francisella infection outcomes are markedly different depend-
ing on the route of infection. In our lab, we have demonstrated 
that the first cells infected, and the resulting immune response dif-
fers depending on the route of infection (7). Intranasal infection 
resulted in a high proportion of alveolar macrophages infected, 
whereas intradermal infection resulted in primarily neutrophils 
being infected. These changes resulted in a distinct adaptive 
immune response. Since Slc11a1 is preferentially expressed in 
macrophages and alveolar macrophages, we speculated that 
the impact of Slc11a1 might differ depending on the route of 
infection.
Pathogen-associated molecular patterns are stimulators of 
innate immune response and play a role in Francisella infection. 
Mice defective in TLR2, but not TLR4 are more susceptible to 
Francisella infection (8). It is striking that these experiments were 
all performed in the absence of a functional Slc11a1 gene. We 
speculated that Slc11a1 might compensate for a TLR2 defect. 
We tested TLR2-deficient mice with and without expression of 
Slc11a1G169 for their resistance to Ft LVS. Surprisingly, Slc11a1G169 
expressing mice were nearly equivalent to TLR2+/Slc11a1G169 
mice indicating that Slc11a1+ can compensate for the lack of 
TLR2 expression.
MaTerials anD MeThODs
Bacteria
Francisella tularensis subsp. holarctica LVS was obtained from 
the Centers for Disease Control (Atlanta, GA, USA). All bacte-
rial studies were carried out with approval from the University 
of Arizona Biosafety Committee. Bacteria were grown at 37°C 
on chocolate agar supplemented with 1% IsoVitalex (Becton 
Dickinson). Inocula were prepared from lawn grown Francisella. 
Bacteria were resuspended in sterile phosphate-buffered saline 
(PBS) at an optical density at 600 nm (OD600) of 1, equivalent of 
1 × 1010 CFU/mL. Innocula were diluted in sterile PBS to obtain 
the desired bacterial dose. Challenge doses were quantified by 
serial dilution and plating on chocolate agar.
Bone Marrow-Derived Macrophage 
(BMDM) generation
Primary BMDMs were cultured from femurs as previously described 
(9). Following differentiation, non-adherent cells were removed by 
multiple washes with PBS and BMDMs were removed from plates by 
scraping. Cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% fetal bovine serum (Atlas), 
l-glutamine (HyClone), sodium pyruvate (HyClone), and penicil-
lin–streptomycin (Life Technologies). Medium was replaced with 
antibiotic-free medium 24 h prior to inoculation with Francisella.
Francisella growth assays
A total of 2  ×  105 BMDM/well were seeded into 96-well flat 
bottom plates (~80% confluent) for Francisella intracellular 
growth assays and incubated 2 h to allow adherence to the plate. 
Cultures were inoculated with LVS at 1 or 100 bacteria per cell. 
Infection was facilitated by centrifugation at 300 × g for 5 min. 
Cells were incubated for 1 h with bacteria, and the medium was 
then removed. Fresh medium containing 50 μg/mL gentamicin 
(Sigma) was added to kill extracellular bacteria. One hour after 
gentamicin addition, medium was removed, and cells washed 
twice before the addition of fresh antibiotic-free medium. To 
determine intracellular growth, medium was removed at indi-
cated time points post-infection, and 200 μL of PBS was added to 
the cultures. Cells were removed from the plate by vigorous pipet-
ting. Cells were lysed by vortexing at maximal speed for 1 min. 
Serial 1:10 dilutions of the lysate were made and plated onto 
chocolate agar. The resulting colonies were counted 48  h later. 
For determination of reactive oxygen species (ROS), BMDM were 
harvested and processed with CellRox Green (ThermoFisher) per 
the manufacturers instructions.
Mice
C57Bl/6J (B6) and B6.129-Tlr2tm1Kir/J (TLR2−/−) mice were 
obtained from The Jackson Laboratories (Bar Harbor, ME) 
and bred in-house. B6 Slc11a1G169 (Slc11a1+) and B6 Slc11a1+ 
Tlr2/4/9−/− (Slc11a1+ Tlr2/4/9−/−) were obtained from Dr. Gregory 
M. Barton (University of California, Berkley) and bred in-house. 
The B6-Slc11a1+ mice are an incipient congenic, having been 
backcrossed to B6 five generations (10). This results in mice that 
are approximately 97% B6 background genes (excepting those 
linked to Slc11a1). The triple knockout has previously described 
and backcrossed to B6 (10). F1 mice (Slc11a1± Tlr2−/− Tlr4± Tlr9±) 
were produced by crossing Slc11a1+ Tlr2/4/9−/− with Tlr2−/−. Loss 
of TLR2 expression was confirmed by flow cytometry. All animal 
protocols were approved by The University of Arizona IACUC.
inoculation of Mice
For intranasal infection, mice were anesthetized with 575  mg/
kg of body weight of tribromomethanol (Avertin; Sigma) 
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administered intraperitoneally. Mice were then intranasally (i.n.) 
inoculated with various doses of LVS suspended in 25 μL PBS. 
For footpad infection, mice were restrained and inoculated with 
LVS suspended in 50 μL PBS in the right footpad. Mice were 
weighed daily following all inoculations. Mice were sacrificed if 
they lost more than 25% of their starting weight, as indicated in 
our University of Arizona IACUC protocol.
Determination of Bacterial Burdens
Spleens, livers, and lungs were homogenized in sterile PBS by using a 
Biojector (Bioject) as previously described (11). Tenfold serial dilutions 
were plated onto chocolate agar. The resulting colonies were counted 
72 h later. The limit of detection (LOD) was 50 CFU per organ.
Preparation of lung cells
Lungs were perfused with PBS to remove blood and then finely minced. 
Minced lung was placed into 10 mL of digestion buffer containing 
0.5  mg/mL collagenase I (Worthington Biochemical), 0.02  mg/mL 
DNase (Sigma), and 125 U/mL elastase (Worthington Biochemical) 
in RPMI 1640 (HyClone). Lungs were digested for 30 min at 37°C 
and then vigorously pipetted prior to filtering through a 100-μm filter. 
Red blood cells were lysed by using ammonium chloride–potassium 
carbonate lysis buffer. Viable cells were determined by trypan blue 
exclusion using a hemacytometer.
Determination of serum and lung 
cytokine Production
Serum and lung cytokines (IL-6, IL-10, MCP-1, IFN-γ, TNF-α, and 
IL-12p70) were determined using a cytometric bead array (CBA) 
Mouse Inflammation Kit (Becton Dickinson) according to the 
manufacturers instructions. For lungs, single cell suspensions were 
incubated in DMEM with antibiotics for 24 h and the supernatant 
was harvested and used for the CBA. Serum was analyzed undiluted.
antibodies and Flow cytometry
The following directly conjugated antibodies were utilized 
for flow cytometry analysis: CD3 (clone 145-2C11; eBiosci-
ence), CD4 (clone GK1.5; Biolegend), CD8a (clone 53-6.7; BD 
Biosciences), CD11b (clone M1/70; Biolegend), CD11c (clone 
N418; Biolegend), CD19 (clone 6D5; Biolegend), F4/80 (clone 
BM8; Biolegend), and GR-1 (Ly-6G) (clone RB6-8C5; eBiosci-
ence). All antibodies were titrated on normal B6 splenocytes prior 
to use. Lung cells were prepared as above. After preparation of 
single cell suspensions, cells were blocked for 30 min at 4°C with 
24G2 serum to block Fc receptors. Cells were then stained with 
indicated antibodies for 30 min at 4°C in the dark. Cells were then 
washed three times with PBS + 2%BSA and analyzed on a Becton 
Dickinson LSRII flow cytometer. FlowJo (Treestar) was used for 
all flow cytometry analysis.
resUlTs
lVs Fails to replicate in Slc11a1+ 
Macrophages
Since Slc11a1 has been previously implicated in control of intra-
cellular bacterial infections and has only been superficially tested 
in Francisella infection, we tested the ability of LVS to replicate in 
BMDMs. We cultured BMDM from both B6 and Slc11a1+ mice 
and confirmed their macrophage phenotype (CD11b+ F4/80+) 
by flow cytometry. The BMDMs were then infected with LVS at 
either a multiplicity of infection (MOI) of 1 (Figure 1A) or 100 
(Figure 1B). Two MOIs were used to ensure adequate infection. 
At 1, 4, and 16  hours post-infection (hpi), macrophages were 
lysed and viable bacterial enumerated. One hour after infection 
there were slightly fewer LVS in Slc11a1+ than B6 BMDM at both 
100 and 1 MOI. By 4 h, there was a decrease in the number of 
LVS recovered from the Slc11a1+ BMDM at an MOI of 100, at the 
MOI of 1 there was no detectable LVS at 4 h in Slc11a1+ BMDM. 
The B6 BMDM had little change in burden at MOI of 100 and 
limited growth at the MOI of 1 at 4 hpi. By 16 h, LVS was still 
undetectable in Slc11a1+ BMDM at an MOI of 1, at the MOI of 
100 there was a 100-fold decrease in bacteria recovered compared 
to the B6 BMDM and 10-fold compared to the Slc11a1+ 1 h after 
infection (Figure 1). Taken together these data indicate that LVS 
is slightly impaired in its ability to invade Slc11a1+ BMDM, but 
more importantly is unable to proliferate after invasion.
Francisella lVs replicates to similar 
levels in following Foot Pad inoculation in 
Slc11a1+ and Slc11a1− Mice
Our in vitro experiments seemed to conflict with the earlier report 
that Slc11a1 increased susceptibility to LVS infection in vivo (5). 
Those experiments used sublethal footpad infection. The report 
of Kovarova used different mouse strains and we needed to test 
their route of infection with our strains. We therefore examined 
the effect of Slc11a1 expression on footpad infection. Slc11a1+ 
and B6 mice were inoculated with a sublethal dose of 1,100 CFU 
of LVS. On days 3 and 7 post-infection, these mice were sacrificed 
and total bacterial burden was determined for the lung, liver, 
and spleen. In contrast to the previous report (5) where there 
was increased bacterial load in Slc11a1+ mice, we observed no 
significant difference in the burdens between Slc11a1+ and B6 
mice in any organ tested at either time point (Figure 2).
Slc11a1+ Mice are resistant to intranasal 
lVs
Since respiratory infection with Francisella alters the immune 
response compared to cutaneous infection, we sought to deter-
mine the role of Slc11a1 in intranasal Francisella infection (7). 
Slc11a1+ and B6 mice were infected with ~1,300 CFU LVS by the 
intranasal route. Mice were monitored for weight loss and survival 
and a subset were sacrificed at day 3 post-infection to determine 
organ burdens. Surprisingly, Slc11a1+ mice did not lose weight 
compared to their starting weight (Figure 3A). By contrast, B6 
mice lost weight starting at day 3. At day 7, 2/5 surviving B6 mice 
had lost greater than 25% of their starting weight and were eutha-
nized as required by our IACUC protocol. The mice who survived 
started regaining weight around day 10 (Figure 3A). In addition 
to maintaining weight, we were not able to recover any viable LVS 
from Slc11a1+ mice (LOD, 50 CFU) in any of the organs tested 
at day 3 post-infection. We recovered high levels of Francisella 
(105–106 CFU) from every organ tested in B6 mice (Figure 3B). 
FigUre 2 | Slc11a1+ mice show no difference compared to B6 in footpad infections with live vaccine strain (lVs). B6 (black circles) or Slc11a1+ (red 
squares) mice were infected with 1,100 CFU of LVS via the footpad. At day 3 (a) or 5 (B) post-infection organs were harvested and bacterial burdens were 
enumerated by plating serial dilutions on chocolate agar. The solid line represents the limit of detection (LOD). A Student’s t-test on log-transformed data was used 
to calculate significance. No significant differences were found. N = 3 mice per time point, data are representative of two independent experiments of similar design.
FigUre 1 | live vaccine strain (lVs) fails to replicate in Slc11a1+ bone marrow-derived macrophage (BMDM). BMDMs from either B6 (black bars) mice or 
Slc11a1+ (red bars) mice were infected with LVS at a multiplicity of infection of 1 (a) or 100 (B). At the indicated times, macrophages were lysed and bacteria were 
enumerated by plating serial dilutions on chocolate agar. The solid line represents the limit of detection (LOD). A Student’s t-test on log-transformed data was used 
to calculate significance. N = 3 wells per time point, data are representative of three experiments of similar design. Error bars indicate SEM.
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These data demonstrate that Slc11a1 plays an important role in 
the resistance of mice to intranasal LVS infection. This is relevant 
to our previous results that demonstrated important differences 
in immune responses between intradermal and intranasal infec-
tion (7).
Slc11a1 expression can compensate for 
lack of Tlr expression
TLR2 has been reported to play a critical role in Ft resistance. 
TLR2-deficient mice are more sensitive to Ft infection that B6 
mice (8, 12). Since SLC11A1+ B6 mice were resistant to intranasal 
LVS infection, we wanted to determine if Slc11a1 expression 
could compensate for the loss of TLR2. We reasoned that Slc11a1+ 
Tlr2/4/9−/− mice would be at least as sensitive as TLR2 KO mice, 
as TLR2 has been strongly linked to resistance to Ft infection. 
We challenged Slc11a1+ Tlr2/4/9−/− mice along with Slc11a1+ and 
B6 mice with ~1,300 CFU of LVS i.n. as above. Similar to earlier 
experiments (Figure 3), most Slc11a1+ mice yielded no detect-
able LVS in the organs (LOD, 20 CFU) while we recovered mice 
high levels of bacteria on day 3 that increased into day 5 from 
B6 mice (Figures 4A,B). Surprisingly, Slc11a1+ Tlr2/4/9−/−, like 
Slc11a1+ mice, yielded 1,000-fold lower organ burdens than B6 
in all organs tested, in spite of lacking TLR2/4/9 (Figures 4A,B). 
TLR4 has little role in Francisella pathogenesis as its unique LPS 
structure fails to bind TLR4. While EF-Tu and DNAK have been 
identified as ligands for TLR4, TLR4-deficient mice show no 
increase in sensitivity Francisella infection compared to B6 mice 
(13–16). TLR2 has been previously demonstrated to be important 
in survival of LVS infection in B6 genetic background mice. These 
experiments demonstrate that the presence of functional Slc11a1 
can compensate for the TLR2 defect in resistance to Ft infection, 
although they are higher than Tlr2+ Slc11a1+ mice.
FigUre 4 | Fewer bacteria are recovered from Slc11a1+ Tlr2/4/9−/− mice than B6 mice following intranasal live vaccine strain (lVs) inoculation. 
C57Bl/6 (black circles), Slc11a1+ (red squares), or Slc11a1+ Tlr2/4/9−/− (blue triangles) mice were intranasally infected with 1,300 CFU of LVS. At 3 (a) and 5 (B) 
days post-infection organs were harvested and bacterial burdens were enumerated by plating serial dilutions on chocolate agar. The solid line represents the limit of 
detection (LOD). A Student’s t-test on log-transformed data corrected for multiple comparisons was used to calculate significance. Unless indicated, differences are 
not significant. N = 3 mice per time point, data are representative of two experiments of similar design.
FigUre 3 | Slc11a1+mice show no weight loss or detectable bacteria after intranasal live vaccine strain (lVs) inoculation. B6 (black circles) or Slc11a1+ 
(red squares) mice were infected with 1,300 CFU of LVS via the intranasal route. (a) Mice were weighed daily as an indication of disease progression. (B) At 3 days 
post-infection organs were harvested from five mice and bacterial burdens were enumerated by plating serial dilutions on chocolate agar. The solid line represents 
the limit of detection (LOD). A Student’s t-test on log-transformed data was used to calculate significance. N = 5 mice per time point, data are representative of 
three experiments of similar design.
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Slc11a1+ Mice Produce little cytokine 
compared to B6 Mice following intranasal 
lVs inoculation
To examine the impact of functional Slc11a1 expression on 
the innate immune response to LVS infection, we measured 
cytokine production in both the serum and lung homogenates 
of Ft infected mice. B6, Slc11a1+, and Slc11a1+ Tlr2/4/9−/− were 
i.n. infected with 1,300 CFU of LVS. Additional B6 and Slc11a1+ 
mice were infected with 1,000 CFU of LVS by the footpad route 
and serum cytokines measured. As a negative control, naïve 
mice received PBS by either the intranasal or footpad route. On 
day 3 and 5 post-infection, mice were sacrificed and cytokine 
production determined. Following the footpad infection, there 
were no significant differences between the B6 and Slc11a1+ mice 
(Figure 5). Both mouse strains produced high levels of IFN-γ, 
MCP-1, and IL-6. This is not surprising since they had similar 
LVS organ burdens in previous experiments (Figure 2). By con-
trast, following intranasal infection, the Slc11a1+ and Slc11a1+ 
Tlr2/4/9−/− mice accumulate very little cytokine in either in 
serum (Figure  6) or lung (Figure  7) after intranasal infection. 
B6 mice had significantly increased levels of IFN-γ and elevated 
levels of MCP-1, and IL-6 in the serum compared to Slc11a1+ and 
Slc11a1+ Tlr2/4/9−/− mice (Figure 6). Lung cultures from B6 mice 
produced significantly more IFN-γ, MCP-1, and IL-6 compared 
to Slc11a1+ and Slc11a1+ Tlr2/4/9−/− cultures (Figure 7). The lack 
of cytokine response seen in Slc11a1+ mice demonstrates it is not 
an increased innate cytokine response that protects Slc11a1+ mice 
and mediates bacterial clearance.
B6 Mice have increased lung cellularity 
after intranasal infection Driven by 
neutrophil recruitment
Because we found so little cytokine in Slc11a1+ mice we hypoth-
esized the cellular milieu in the lung would differ after infection. To 
determine the total cellularity of lungs B6, Slc11a1+, and Slc11a1+ 
Tlr2/4/9−/− were i.n. infected with 1,300 CFU of LVS, naïve mice 
received PBS as a control. At day 3 and 5 post-infection, mice 
were sacrificed and lungs were harvested, the right lobe was used 
FigUre 5 | Slc11a1+ and B6 mice produce similar cytokine following live vaccine strain (lVs) inoculation in the footpad. B6 (black bars) or Slc11a1+ (red 
bars) mice were inoculated with 1,300 or 1,100 CFU of LVS in the footpad. Serum was harvested after 3 and 5 days, and cytokine was quantified by cytometric 
bead array. A Student’s t-test was used to calculate significance. Unless indicated, differences are not significant. N = 3 mice per time point, data are representative 
of two independent experiments of similar design.
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for CFU determination (Figure 4) and the left lobe was used for 
lung cellularity counts and flow cytometry (Table 1). The naïve 
mice had no significant changes in total lung cellularity among 
strains. Consistent with previously published data, B6 mice dem-
onstrated a significant increase in total lung cellularity at both 
days 3 and 5 (17). Strikingly in Slc11a1+ mice, we detected no 
increased cellularity compared to naïve mice at either 3 or 5 days 
post-infection. The lack of cellular infiltrate in the Slc11a1+ is 
striking, but consistent with the low levels of bacteria present. We 
detected only a moderate increase of cellularity in the Slc11a1+ 
Tlr2/4/9−/− mice at day 3 although still significantly lower than the 
B6 mice. By day 5, the cellularity of all Slc11a1+ Tlr2/4/9−/− mice 
had decreased close to naïve levels although B6 levels remained 
high (Table 1).
To determine which cells are responsible for this increased 
cellularity, samples were stained for flow cytometric analy-
sis. The gating strategy for this analysis is in Figure S1 in 
Supplementary Material. Both the total number and the 
percentage of macrophages, dendritic cells, neutrophils, T, and 
B lymphocytes were determined. In B6 mice, two cell types 
were significantly increased, in both number and percentage. 
Neutrophils (CD3−, CD19−, CD11b+, Gr-1+) and monocyte/
macrophages (CD3−, CD19−, CD11b+, Gr-1−, F4/80−) (Table 1) 
were increased. There was no significant difference in any other 
population in either Slc11a1+ or Slc11a1+ Tlr2/4/9−/− mice. This 
is consistent with Figure 1 showing the inability of Francisella 
to replicate in the myeloid cells of Slc11a1+ mice. Thus, the 
resistance to infection is not due to increased recruitment of 
innate cells, but rather a cell intrinsic property of the resident 
infected cells of Slc11a1+ mice.
Following lVs infection Slc11a1+ Mice 
Produce More rOs than B6 Mice
One mechanism used by Francisella for controlling the innate 
immune response is the reduction of host produced ROS (18, 
19). To examine the ability of Slc11a1+ cells to produce ROS in 
response to LVS infection, BMDMs were cultured from B6 and 
Slc11a1+ mice and infected. We measured ROS production every 
10 min. Control cells were treated with 70% tert-butyl hydroper-
oxide as a positive control or left untreated. Control cultures were 
harvested at 50 min after the infection. Both untreated B6 and 
Slc11a1+ BMDM produced similar low levels of ROS. In response 
to the positive control, tert-butyl hydroperoxide, the Slc11a1+ 
BMDM made significantly more ROS than the B6 cells. As seen 
previously, the B6 cells made little ROS in response to LVS infec-
tion. Strikingly, the Slc11a1+ BMDM made significantly more 
ROS in response to LVS starting at 20  min after infection and 
increasing throughout the assay (Figure 8). Thus the expression 
of functional Slc11a1 overrides the inhibition of ROS produc-
tion by Francisella presumably mediating better early pathogen 
control both in vitro and in vivo.
Slc11a1+ Mice are resistant to high-Dose 
intranasal lVs challenge
Because of the low bacterial proliferation in Slc11a1+ mice, we 
hypothesized that Slc11a1+ mice would be resistant to high-dose 
LVS challenge. In order to determine the extent of protection 
conferred by a functional Slc11a1—B6, Slc11a1+, Slc11a1+ 
Tlr2/4/9−/−, and Slc11a1± Tlr2−/− Tlr4± Tlr9± mice were challenged 
i.n. with increasing doses of LVS and monitored for survival. B6 
FigUre 6 | Slc11a1+ mice show little detectable changes in serum cytokines after live vaccine strain (lVs) intranasal inoculation. C57Bl/6 (black bars), 
Slc11a1+ (red bars), or Slc11a1+ Tlr2/4/9−/− (blue bars) mice were infected with 1,300 CFU of LVS intranasally. Serum was harvested and cytokines were quantified 
by cytometric bead array. A Student’s t-test corrected for multiple comparisons was used to calculate significance. Unless indicated, differences are not significant. 
N = 3 mice per time point, data are representative of two independent experiments of similar design.
FigUre 7 | Slc11a1+ mice show little detectable changes in lung cytokine after live vaccine strain (lVs) intranasal infection. B6 (black bars), Slc11a1+ 
(red bars), or Slc11a1+ Tlr2/4/9−/− (blue bars) mice were inoculated with 1,300 CFU of LVS via the intranasal route. At the indicated time point, lungs were harvested 
and processed into a single cellular suspension. After 24 h incubation, supernatants were harvested and cytokines were quantified by cytometric bead array. A 
Student’s t-test corrected for multiple comparisons was used to calculate significance. Unless indicated, differences are not significant. N = 3 mice per time point, 
data are representative of two independent experiments of similar design.
7
Powell and Frelinger NRAMP-Mediated Resistance is Route Dependent
Frontiers in Immunology | www.frontiersin.org March 2017 | Volume 8 | Article 206
mice only received 8,700 CFU of LVS (~8 LD50). All B6 mice suc-
cumbed to infection by day 8 as expected. Slc11a1+ mice received 
either 8,700 CFU (~8 LD50) or 87,000 (~80 LD50) of LVS. All mice 
(5/5) survived the 8,700 CFU challenge and 80% (4/5) survived 
the 87,000  CFU challenge. Slc11a1+ Tlr2/4/9−/−, and Slc11a1± 
Tlr2−/− Tlr4± Tlr9± had similar survival with all mice surviving the 
8,700 CFU challenge and 60% of Slc11a1+ Tlr2/4/9−/−, and 100% 
of Slc11a1± Tlr2−/− Tlr4± Tlr9± survived the 87,000 CFU challenge 
TaBle 1 | cell subtypes in lung after live vaccine strain infection.
c57Bl/6 scl11a1+ Tlr2/4/9−/−  
slc11a1+
c57Bl/6 slc11a1+ Tlr2/4/9−/−  
slc11a1+
c57Bl/6 slc11a1+ Tlr2/4/9−/−  
slc11a1+
Day 0 Day 0 Day 0 Day 3 Day 3 Day 3 Day 5 Day 5 Day 5
Total cells/
lobe
3.40 × 106  
± 2.08 × 105
3.50 × 106 
 ± 1.73 × 105
3.50 × 106  
± 1.73 × 105
6.77 × 106 
 ± 2.60 × 105
3.53 × 106  
± 6.67 × 104
5.33 × 106  
± 6.67 × 104
7.63 × 106  
± 2.61 × 105
3.67 × 106  
± 2.60 × 105
4.40 × 106  
± 2.60 × 105
NS NS p = 0.0006 p = 0.0120 p = 0.0002 p = 0.0006
Neutrophils 
(CD3−, 
CD19−, 
CD11cVar, 
CD11b+, 
Gr-1+)
9.79 × 104  
± 1.06 × 104
8.64 × 104  
± 1.11 × 104
7.77 × 104  
± 2.33 × 104
1.23 × 106  
± 3.49 × 105
2.45 × 105  
± 2.03 × 104
4.13 × 105  
± 9.88 × 104
7.63 × 106  
± 2.60 × 105
2.30 × 105  
± 5.57 × 104
4.24 × 105  
± 2.00 × 104
NS NS NS NS p < 0.0001 p < 0.0001
Macrophages 
(CD3−, 
CD19−, 
CD11cVar, 
CD11b+, 
Gr-1− 
F4/80low)
8.91 × 104  
± 6.28 × 103
8.57 × 104  
± 2.99 × 103
9.32 × 104  
± 8.42 × 103
4.48 × 105  
± 7.26 × 104
1.78 × 105  
± 1.93 × 104
2.35 × 105  
± 8.24 × 103
6.37 × 105  
± 2.14 × 105
1.79 × 105  
± 4.79 × 104
1.51 × 105  
± 1.50 × 104
NS NS p = 0.046 NS NS NS
Macrophages 
(CD3−, 
CD19−, 
CD11cVar, 
CD11b+, 
Gr-1− 
F4/80mid)
8.75 × 105  
± 4.74 × 103
8.07 × 105  
± 1.57 × 104
5.15 × 105  
± 8.39 × 103
1.41 × 105  
± 8.44 × 104
6.90 × 104  
± 4.09 × 103
1.48 × 105  
± 3.06 × 103
7.07 × 104  
± 1.66 × 104
6.11 × 104  
± 1.53 × 104
9.35 × 104  
± 3.21 × 104
NS NS NS NS NS NS
Dendritic 
cells (CD3−, 
CD19−, 
CD11c+, 
CD11b−, 
F4/80low)
1.21 × 104  
± 2.44 × 102
1.41 × 104  
± 1.13 × 103
1.60 × 104  
± 4.39 × 103
4.59 × 104  
± 1.42 × 104
1.71 × 104  
± 8.83 × 102
2.62 × 104  
± 7.49 × 102
5.11 × 104  
± 2.05 × 104
2.03 × 104  
± 1.85 × 103
2.45 × 104  
± 4.09 × 103
NS NS NS NS NS NS
Alveolar 
macrophages 
(CD3−, 
CD19−, 
CD11c+, 
CD11b−, 
F4/80mid)
5.22 × 104  
± 3.66 × 103
5.25 × 104  
± 1.00 × 104
4.37 × 104  
± 9.84 × 103
1.15 × 105  
± 2.68 × 104
9.70 × 104  
± 1.45 × 103
2.36 × 105  
± 6.461 × 103
3.22 × 104  
± 6.01 × 103
4.76 × 104  
± 3.79 × 103
9.97 × 104  
± 1.90 × 104
NS NS NS p = 0.0234 NS NS
Summary of total number of each cell type in the lungs of infected mice. Significant differences were made by comparing each strain to B6 at that time point (NS = not significant). A Student’s t-test corrected for multiple comparisons 
was used to calculate significance. N = 3 mice per time point.
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FigUre 8 | Slc11a1+ bone marrow-derived macrophage (BMDM) show 
increased reactive oxygen species (rOs) compared to B6 in response 
to live vaccine strain (lVs) infection. BMDMs were generated from either 
B6 (black circles) mice or Slc11a1+ (red circles) mice and infected with LVS at 
a multiplicity of infection 10. Control cells were treated for 50 min with 200μM 
tert-butyl hyperoxide (TBHP). At the indicated time point, macrophages were 
harvested and processed for determination of ROS by CellROX green on the 
flow cytometer. A Student’s t-test corrected for multiple comparisons was 
used to calculate significance. N = 3 wells per time point. Data are 
representative of two independent experiments of similar design.
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(Figure 9). This resistance to even very high-dose challenges of 
LVS, even in the absence of TLR2, highlights the strong effect 
functional Slc11a1 has the outcome of LVS infection.
DiscUssiOn
Slc11a1 has been implicated in a variety of intracellular infec-
tions including Salmonella and Mycobacterium (20). The exact 
mechanism of Slc11a1 restriction of pathogen replication is 
unclear, but some work seems to indicate that it is iron restriction 
outside of the vesicle. Slc11a1 is a transporter of both ferrous iron 
(Fe2+) and manganese (Mn2+) (21), both of which are important 
in ROS production and suggest a mechanism for the effect of 
Slc11a1 expression. In Mycobacterium infections excess iron can 
overwhelm the Slc11a1 restriction (22–24). It is clear that Slc11a1 
restriction is dependent on pathogens passing through a LAMP-
1+ vesicle, intracellular pathogens that avoid LAMP-1+ vesicles 
such as Listeria are not restricted by Slc11a1 (20). Francisella is 
sensitive to iron starvation when cells are treated with bafilomycin 
A to limit Francisella escape into the cytosol, sequestration of iron 
by Slc11a1 may play a role in the resistance to LVS infection (25, 
26). Initial studies in BMDM indicated that LVS was only slightly 
deficient in invasion of Slc11a1+ macrophages and supported no 
discernable growth. By contrast, LVS replicated robustly in B6 
BMDM, indicating an early event after entry that restricts growth 
in Slc11a1+ BMDM. There is evidence that Francisella is able to 
spread cell to cell through trogocytosis (27), while not specifically 
examined in our experiments, the fact that LVS is unable to repli-
cate in Slc11a1+ cells, either in vivo or in vitro, indicates cell to cell 
spread does not allow LVS to escape Slc11a1-mediated resistance.
Previous work had indicated that expression of Slc11a1 
enhanced LVS proliferation following footpad inoculation (5). 
In our hands, we saw no significant difference between B6 and 
Slc11a1+ mice following footpad infection (Figure 2). One dif-
ference in our study design was using a higher dose of LVS in 
the footpad (103 vs. 102). This increased dose may account for 
why we were unable to see the small difference that was seen in 
the study by Kovarova et al. Additionally, the background of the 
mouse strains is different (B6 vs. B10), which may also contribute 
to the fact we saw no difference in the footpad infection. Other 
genes on chromosome 1 that differ between the Slc11a1 donor in 
the A/J and the 129 and could be passengers in the congenics. In 
our experiments they could have epistatic effects that could also 
contribute to these differences. By contrast, when we challenged 
mice i.n., Slc11a1+ mice were significantly more resistant to LVS 
than B6 mice. Functional Slc11a1 expression in C3H/HeN and 
129/J mice is not sufficient to survive a highly virulent type A 
(Strain 33) challenge (28, 29). This might be due to differences in 
either the genetic background of the mice or differences between 
Francisella Strain 33 and LVS. Other host genetic differences 
among mouse strains remain to be explored. A recent study by 
Fink et  al. examined quantitate trait loci (QTL) following LVS 
infection (6). They reported that A/J mice, which are Slc11a1+, 
are more sensitive to LVS infection as compared to B6 mice. 
Recombinant inbred (RI) mice between these two strains were 
tested and QTL analysis performed. Three QTL were found to be 
significant, one region on chromosome 1 that includes the Slc11a1 
gene, one on chromosome 2, and a large region of chromosome 
19. Further analysis demonstrated the QTL on chromosomes 1 
and 2 was epistatic. This indicates that the genetic variation on 
chromosome 2 of A/J mice acts in concert with the Slc11a1 region 
on chromosome 1. Our Slc11a1+ mice, being incipient congenics, 
are highly likely to be same as B6 mice on chromosome 2, lack-
ing whatever element from A/J is interacting with the Slc11a1 
region on chromosome 1. Combined with our data it seems that 
functional Slc11a1 expression in a B6 background in beneficial 
for LVS infection, whereas with the interactions from chromo-
some 2 Slc11a1 expression can be detrimental. Further RI strains, 
with more founder strains such as the Collaborative Cross, will 
be needed to narrow the region on chromosome 2 that interacts 
with Slc11a1 (30). While the B6 Slc11a1+ strain does still con-
tain 129 DNA surrounding the Slc11a1 allele (10), the F1 cross 
(B6-Tlr2−/− Slc11a1D/D X B6-Tlr2,4,9−/− Slc11a1G/G) we have made 
should be heterozygous in that region of chromosome 1. Since 
this F1 strain behaves similar to the parental strain B6-Tlr2,4,9−/− 
Slc11a1G/G we feel confident that the remaining 129 DNA is not 
confounding our results (Figure 9A). In our hands, all Slc11a1+ 
mice showed marked resistance to intranasal LVS infections. 
Slc11a1+ mice had little to no detectable bacteria by day 3 post-
infection. Additionally, when Slc11a1+ were challenged i.n. with 
escalating doses of LVS they were able to survive challenges of 
87,000 CFU (80 LD50). B6-Slc11a1+ were also resistant to a fully 
virulent murine Francisella novicida challenge by the intranasal 
route (data not shown). The Slc11a1+ mice also had no change in 
total lung cellularity. B6 mice show a large influx of macrophages 
and neutrophils as well as increased production of IFN-γ, MCP-1, 
and IL-6. This lack of change in cellularity may be linked with 
the lack of cytokine production in Slc11a1+ mice. Taken together 
it would seem that resident lung cells are carrying out the rapid 
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FigUre 9 | Slc11a1+ mice are resistant to high-dose challenges of live vaccine strain (lVs) by the intranasal route. B6 [black lines (a–c)], Slc11a1+ [red 
lines (a)], Slc11a1+ Tlr2/4/9−/− [blue lines (B)], or Slc11a1± Tlr2−/−/4±/9± [green lines (c)] mice were infected with the indicated doses of LVS via the intranasal route. 
Mice were monitored for survival and signs of disease. Significance was determined using a Mantel–Cox log rank test. N = 5 mice per group.
clearance of Francisella. Previous work by our laboratory and oth-
ers has demonstrated that Francisella can infect a variety of cells 
and these infected cells differ by route of infection (17, 31–33). 
Particularly of interest is the fact that alveolar macrophages are 
the primary infected cell in the lung after intranasal infection 
whereas after intradermal infection the primary infected lung cells 
are interstitial macrophages and neutrophils (7). Experiments on 
PMNs, which do not express Slc11a1, indicate that LVS infection 
of PMNs prolongs their life span, whereas LVS has been shown 
to induce cell death in macrophages (34–37). These differential 
effects depending on cell type may help explain the differences 
seen in Slc11a1+ mice depending on the route of infection.
The rescue of the TLR2 defect was surprising. TLR2 has 
been reported by a variety of groups to be critical in survival of 
Francisella infection (8, 11, 12, 15, 38). This work has been carried 
out in the Slc11a1− B6 background. Functional Slc11a1 can not 
only overcome a lack of TLR2, but Slc11a1+ Tlr2−/− mice are more 
resistant to intranasal LVS infection than B6 mice. B6-Tlr2/4/9−/− 
(Slc11a1−) mice are not available to used as a control, though 
we expect they would behave like B6-Tlr2−/− mice as TLR4 and 
TLR9 have little role in Francisella infection (39, 40). Further 
work is needed to determine if Slc11a1+ mice are resistant to fully 
virulent human Francisella strains such as SchuS4. A variety of 
live attenuated mutants have been generated in both LVS and the 
type A strain SchuS4. While attenuation has been relatively easily 
achieved, full protection against a type A challenge has been rare 
and even successful vaccines only have protected against limited 
doses of highly virulent bacteria [reviewed in Ref. (41)]. Since 
most humans express a functional Slc11a1, retesting of these 
vaccine candidates in a Slc11a1+ background may yield more 
applicable results.
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